Skip to content

Drug interactions

Lomitapide + Nevirapine

Severity: Moderate

Lomitapide and Nevirapine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nevirapine is a CYP3A4 inducer, so lomitapide exposure would be expected to fall rather than rise. This may reduce lipid-lowering efficacy.

What this interaction means in plain words

Lomitapide and Nevirapine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lomitapide belongs to Cardiovascular; Nevirapine belongs to Anti Virals.

Evidence level: Low

Why it happens

Nevirapine induces CYP3A4, which is the main metabolic pathway for lomitapide.

What to do

Monitor LDL cholesterol and adjust the lomitapide dose according to response and liver tests.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Nevirapine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Nevirapine?

MediHelp rates the interaction as moderate. Lomitapide and Nevirapine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nevirapine is a CYP3A4 inducer, so lomitapide exposure would be expected to fall rather than rise. This may reduce lipid-lowering efficacy.

How serious is the interaction between Lomitapide and Nevirapine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor LDL cholesterol and adjust the lomitapide dose according to response and liver tests.

What other medicines interact with Nevirapine?

MediHelp also lists interactions of Nevirapine with, for example, Elbasvir / grazoprevir, Ranolazine, St john's wort. The full list is on the Nevirapine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in